New York Life Investment Management’s Emcor EME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.14M Sell
6,189
-55
-0.9% -$46.5K 0.04% 346
2026
Q1
$4.61M Buy
6,244
+80
+1% +$58.2K 0.04% 339
2025
Q4
$3.77M Buy
6,164
+59
+1% +$38.2K 0.03% 375
2025
Q3
$3.97M Buy
+6,105
New +$3.7M 0.03% 379
2024
Q4
Sell
-5,607
Closed -$2.41M 836
2024
Q3
$2.41M Sell
5,607
-311
-5% -$117K 0.02% 528
2024
Q2
$2.16M Buy
5,918
+1,177
+25% +$434K 0.02% 535
2024
Q1
$1.66M Sell
4,741
-203
-4% -$54.5K 0.02% 582
2023
Q4
$1.07M Sell
4,944
-70
-1% -$14.7K 0.01% 646
2023
Q3
$1.05M Buy
5,014
+2,685
+115% +$562K 0.01% 615
2023
Q2
$430K Buy
+2,329
New +$390K ﹤0.01% 884

Other funds holding EME

New York Life Investment Management's EME Position: Q2 2026 in Review

New York Life Investment Management reduced its Emcor (EME) stake by 0.88% in Q2 2026, selling an estimated $46.5K and leaving 6,189 shares worth $5.14M. The position accounts for 0.04% of the portfolio, ranked #346.

New York Life Investment Management first reported a position in EME in Q2 2023 and has held it in 10 quarters since. 995 funds tracked by Wall St. Rank hold EME as of Q2 2026.

  • New York Life Investment Management held 6,189 shares of Emcor worth $5.14M as of Q2 2026.
  • New York Life Investment Management sold 55 Emcor shares in Q2 2026, an estimated $46.5K.
  • Emcor made up 0.04% of New York Life Investment Management's portfolio in Q2 2026, its #346 holding.
  • New York Life Investment Management first reported a position in Emcor in Q2 2023 and has held it in 10 quarters since.
  • 995 funds tracked by Wall St. Rank held Emcor as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.